TLR4 stimulation is known to contribute to acute lung injury after administration of inactivated influenza virus; here, the synthetic TLR4 antagonist Eritoran is shown to protect mice from death after infection with a lethal dose of the virus.
- Kari Ann Shirey
- Wendy Lai
- Stefanie N. Vogel